| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $34,858,385 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 000 | 3 | NIH | 1/17/2025 | $334,284 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY037126 | The Role of mtDNA/ZBP1 in Retinal Neurodegeneration | 000 | 1 | NIH | 1/17/2025 | $618,088 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH077303 | Synaptic Organizers: Dynamic Regulation of Trans-synaptic Bridges | 002 | 18 | NIH | 11/29/2024 | $627,800 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK077148 | Metabolic and xenobiotic control of thyroid hormone metabolism | 001 | 12 | NIH | 4/24/2025 | $438,571 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI185231 | Modulation of viral genome packaging in Rift Valley fever virus | 000 | 2 | NIH | 5/15/2025 | $200,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 000 | 4 | NIH | 1/2/2025 | $178,432 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 000 | 4 | NIH | 1/2/2025 | $75,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UH3NS128397 | Chronic Subdural Hematoma Treatment with Embolization vs Surgery or MedicalManagement Study (CHESS) | 000 | 2 | NIH | 3/27/2025 | $2,854,548 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21NS140036 | Utilizing a novel hamster model to determine neurologic and behavioral abnormalities of offspring from mothers infected with SARS-CoV-2 | 000 | 1 | NIH | 12/11/2024 | $240,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM150459 | Dynamic regulatory impact of human transposable elements on gene expression | 000 | 3 | NIH | 5/19/2025 | $387,465 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK132072 | Targeting bone marrow to treat renal disease | 000 | 3 | NIH | 12/9/2024 | $424,750 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184781 | Pre-clinical studies to repurpose FDA-approved adenosine A2A receptor antagonists for lethal rickettsial infection | 000 | 1 | NIH | 6/11/2025 | $463,698 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG089708 | Selective vulnerability and resilience to trans-synaptic pathological tau spreading in Alzheimers disease | 001 | 2 | NIH | 4/28/2025 | $20,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG089708 | Selective vulnerability and resilience to trans-synaptic pathological tau spreading in Alzheimers disease | 000 | 2 | NIH | 3/27/2025 | $180,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034616 | Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina | 000 | 3 | NIH | 4/11/2025 | $541,883 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA060221 | Frustration effects on drug taking | 000 | 2 | NIH | 4/23/2025 | $400,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AG084149 | The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults | 001 | 2 | NIH | 5/29/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AG084149 | The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults | 000 | 2 | NIH | 12/18/2024 | $37,666 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 001 | 3 | FDA | 12/16/2024 | $107,439 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 000 | 3 | FDA | 12/12/2024 | $400,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 001 | 3 | NIH | 11/21/2024 | $388,626 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS128410 | Role of Primary Sensory Neuron CaMKII Signaling in Regulation of Pain | 002 | 3 | NIH | 5/2/2025 | $630,092 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U3REP220679 | Regional Emerging Special Pathogen Treatment Center Cooperative Agreement | 01 | 3 | ASPR | 1/17/2025 | $2,000,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HD113193 | Investigating the molecular mechanism of P-gp/NHERF-1 network at feto maternal interface and role of paracrine signaling of EVs containing drug transporter proteins | 000 | 3 | NIH | 5/29/2025 | $280,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI160226 | Preclinical development of a vaccine for Nipah virus | 000 | 4 | NIH | 6/2/2025 | $1,157,701 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI178318 | Targeting HNF4-induced thrombo-inflammation in Chagas disease | 000 | 3 | NIH | 5/21/2025 | $179,118 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI191804 | Mechanism of Lassa virus-associated sensorineural hearing loss | 000 | 1 | NIH | 5/2/2025 | $38,372 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM158090 | Function and application of contractile injection systems and jumbophage RNA polymerases | 000 | 1 | NIH | 5/14/2025 | $440,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184768 | Circularization of RNA to improve the durability of the vaccine immune response | 000 | 1 | NIH | 5/7/2025 | $798,400 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | S10OD038289 | Waters Desorption Electrospray (DESI) XS TQ Absolute imaging mass spectrometry system | 000 | 1 | NIH | 4/30/2025 | $593,598 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM158272 | Structural bases for protein synthesis quality control | 000 | 1 | NIH | 5/12/2025 | $375,420 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P01AI150585 | Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus | 000 | 5 | NIH | 4/16/2025 | $2,295,613 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK125730 | ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE | 000 | 5 | NIH | 2/28/2025 | $388,872 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH128082 | Metabolic strategies to eliminate CNS Myeloid Viral Reservoirs | 000 | 5 | NIH | 4/30/2025 | $425,936 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI191684 | Identification of Cross-Protective Surface Antigens in Burkholderia Species | 000 | 1 | NIH | 4/24/2025 | $38,372 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM130326 | Dynamics of DNA scanning and recognition by proteins | 003 | 7 | NIH | 1/15/2025 | $482,400 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 4 | NIH | 3/9/2025 | $198,400 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 4 | NIH | 3/9/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG054025 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease | 000 | 9 | NIH | 3/14/2025 | $690,520 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA052263 | AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | 001 | 5 | NIH | 4/10/2025 | $59,389 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA052263 | AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | 000 | 5 | NIH | 2/26/2025 | $534,501 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077253 | The Role of Ubiquitination in Tau Oligomers Pathogenesis | 000 | 4 | NIH | 3/14/2025 | $673,497 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI176670 | Porous silicon microparticle-based subunit vaccines for SARS-CoV-2 | 000 | 3 | NIH | 2/13/2025 | $681,312 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK133364 | Role of proteolytic suPAR fragment in insulin dependent diabetes and kidney disease | 004 | 4 | NIH | 5/21/2025 | $661,884 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AG075725 | tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer’s Disease | 000 | 3 | NIH | 2/14/2025 | $695,548 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 4 | NIH | 3/10/2025 | $118,383 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 4 | NIH | 3/10/2025 | $74,331 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 4 | NIH | 3/10/2025 | $100,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH132226 | Probing brain circuit and behavior with protein:protein interaction modulators | 000 | 3 | NIH | 2/13/2025 | $675,098 |
|
